Thalamus AI
Analysis completed on 3/13/2026
The submission exhibits significant red flags, including unsupported and highly exaggerated claims of traction ('most people have used my product') and audience reach ('everyone'). For a clinical medicine AI tool launched in 2017, the lack of verifiable metrics, completely generic technical descriptions, and unusual financial metrics ('all time marketcap: 500000') severely diminish credibility. All claims are vague and unsupported, resulting in minimum quality multipliers across the board.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline